附加主动外联策略对药物干预试验研究入组的效果与效率
该研究基于MaCK随机试验的入组数据,回顾性分析2019年8月至2021年6月期间退伍军人慢性肾脏病患者的入组情况,比较附加主动外联与被动邮件邀请策略的效果与效率。结果显示,主动外联策略的成功接触率、入组率和随机化率均显著高于被动策略,且每次成功接触、入组和随机化所需员工时间更少。结论认为,对于风险超过最低限度的研究,附加主动外联策略在招募效果和效率上比被动策略高4至10倍。
要点
- 主动外联策略成功接触率77.1% vs 被动策略7.1%(P < .001)。
- 主动外联策略入组率15.5% vs 被动策略1.7%(P < .001)。
- 主动外联策略随机化率7.4% vs 被动策略1.34%(P < .001)。
核心结论
- 对于风险超过最低限度的研究,附加主动外联策略在实现研究招募方面比被动外联策略有效且高效4至10倍。
- 这些发现强烈支持在涉及药物或器械干预的常规研究中更多使用此类策略。
研究设计与样本
- 对MaCK随机试验2019年8月至2021年6月入组数据的回顾性分析。
- 通过电子健康记录查询获得退伍军人慢性肾脏病源队列,邮寄邀请信并要求2周内回电。
- 未在2周内回复者,在有限豁免《健康保险携带和责任法案》下由研究人员主动联系。
主要发现
- 从电子数据库抽样的747例患者接受邮件邀请被动外联,其中258例仍符合主动外联条件。
- 主动外联策略成功接触率77.1% vs 被动策略7.1%(P < .001)。
- 主动外联策略入组率15.5% vs 被动策略1.7%(P < .001)。
- 主动外联策略随机化率7.4% vs 被动策略1.34%(P < .001)。
- 主动外联策略每次成功接触所需员工时间14.8 ± 0.4分钟 vs 被动策略2.7 ± 0.2分钟(P < .0001);每次入组66.1 ± 1.6分钟 vs 13.4 ± 0.9分钟(P < .0001);每次随机化85.9 ± 2.1分钟 vs 28.3 ± 1.8分钟(P < .0001)。
关键数值与推荐
- 效果主要结局:成功入组率;效率主要结局:每次入组所需努力。
- 成功接触率77.1% vs 7.1%(P < .001);入组率15.5% vs 1.7%(P < .001);随机化率7.4% vs 1.34%(P < .001)。
临床怎么用
- 作者认为,将主动外联策略纳入器械或药物干预试验可能让更多感兴趣的人参与,从而可能改善研究参与的公平性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Adding an active outreach strategy for patients who do not respond to mail invitations may enhance clinical research recruitment; however, the effectiveness of this approach has yet to be formally tested in drug intervention trials. Using the enrollment data from the Management of Cardiovascular disease in chronic Kidney disease (MaCK) randomized trial, we aimed to evaluate the effectiveness and efficiency of the add-on active outreach compared to the mail invitation-based passive enrollment strategy. STUDY DESIGN AND SETTINGS: We conducted a retrospective analysis of enrollment data from August 2019 to June 2021 for the MaCK trial. We used an electronic health records (EHRs) query to derive the source cohort of Veterans with chronic kidney disease. We mailed them an invitation to participate in the study, with a brief study description and a request for a call-back within 2 weeks, irrespective of their interest in participation. Invitees not responding within 2 weeks were proactively contacted under a limited Health Insurance Portability and Accountability Act waiver. The effectiveness, defined as the rates of successful enrollments, and the efficiency, defined as the effort per enrollment, were the coprimary outcomes. The effectiveness and efficiency of successful approaches and randomizations were the secondary outcomes. RESULTS: Among the 747 patients sampled from the electronic database for the mail invitation-based passive outreach, 258 remained eligible for proactive contact by research staff under the active outreach strategy. Compared to the passive mail invitation-based outreach, the add-on active outreach strategy was more effective, with higher approach success rates (77.1% vs 7.1%; P < .001), enrollment rates (15.5% vs 1.7%, P < .001), and randomization rates (7.4% vs 1.34%, P < .001). Compared to the passive outreach, the active outreach strategy was also more efficient, with lower staff effort required for making a successful approach (14.8 ± 0.4 vs 2.7 ± 0.2 minutes, P < .0001), study enrollment (66.1 ± 1.6 vs 13.4 ± 0.9 minutes, P < .0001), and randomization (85.9 ± 2.1 vs 28.3 ± 1.8 minutes, P < .0001). CONCLUSION: An add-on active outreach strategy is 4- to 10-fold more effective and efficient in achieving research recruitments than a passive outreach strategy for more-than-minimal-risk studies. These findings strongly argue for a greater use of these strategies for conventional research studies involving drug or device interventions. PLAIN LANGUAGE SUMMARY: Actively reaching out to people who were mail-invited for research studies but did not respond may allow more people the opportunity for research participation and increase clinical research recruitments; however, the effectiveness of such an approach has not been formally tested for research studies outside the population and behavioral health. This retrospective analysis of a randomized drug intervention clinical trial shows that employing such an active outreach strategy increases the research participation and efficiency by 5- to 10-fold. The analysis further shows that establishing a successful contact with the potential research participant is the major determinant of overall enrollments, irrespective of the recruitment strategy. At the same time, the study did not identify any major concerns for safety or privacy among potential participants contacted. These findings suggest that incorporating the active outreach strategy for the device or drug intervention trials may allow more interested people to participate and, as such, may improve equity in research participation.
引用
- Joyce M, Sharma S, Ly L, et al. Effectiveness and efficiency of an add-on active outreach strategy on research enrollments in a drug intervention trial. J Clin Epidemiol. 2025. PMID: 40992520. doi:10.1016/j.jclinepi.2025.111986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。